ACTR-75. A MULTICENTER, 3-ARM, OPEN-LABEL, PHASE IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF TANIBIRUMAB (VEGFR2 MAB), IN PATIENTS WITH RECURRENT GBM ASSESSED WITH K-TRAN...

Por Cher, Lawrence, Nowak, Anna, Iatropoulos, George, Lee, Weon Sup, Lee, Seon Young, Shim, Sang Ryeol, Yoo, Jin San
Publicado no Neuro Oncol (2017)

Intravitreal Tanibirumab, a Fully Human Monoclonal Antibody Against Vascular Endothelial Growth Factor Receptor 2, Partially Suppresses and Regresses Laser-Induced Choroidal Neovas...

Por Kim, Jaeryung, Kim, Tae Eun, Kim, Ju-A, Yun, Ji-Hyun, Sohn, Seongsoo, Shim, Sang Ryeol, Lee, Sang Hoon, Kim, Sang Jin
Publicado no J Ocul Pharmacol Ther (2014)

Caspase-mediated Cleavage of p130cas in Etoposide-induced Apoptotic Rat-1 Cells

Por Kook, Seunghyi, Shim, Sang Ryeol, Choi, Soo Jeon, Ahnn, Joohong, Kim, Jae Il, Eom, Soo Hyun, Jung, Yong Keun, Paik, Sang Gi, Song, Woo Keun
Publicado em 2000

Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angioge...

Por Kim, Dong Geon, Jin, Younggeon, Jin, Juyoun, Yang, Heekyoung, Joo, Kyeung Min, Lee, Weon Sup, Shim, Sang Ryeol, Kim, Sung-Woo, Yoo, Jinsang, Lee, Sang Hoon, Yoo, Jin-San, Nam, Do-Hyun
Publicado no MAbs (2015)

TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis

Por Lee, Weon Sup, Pyun, Bo-Jeong, Kim, Sung-Woo, Shim, Sang Ryeol, Nam, Ju Ryoung, Yoo, Ji Young, Jin, Younggeon, Jin, Juyoun, Kwon, Young-Guen, Yun, Chae-Ok, Nam, Do-Hyun, Oh, Keunhee, Lee, Dong-Sup, Lee, Sang Hoon, Yoo, Jin-San
Publicado no MAbs (2015)